α-Gustducin knockout mice did not gain as much weight as WT mice on HFD. Intragastric administration of bitter agonists caused further weight loss via α-gustducin pathway. Therefore, α-gustducin is involved in induction of obesity during HFD. This evidence concerns the gene GNAT3 and Obesity.